With the publication of the AdreView Myocardial Imaging for Risk Evaluation in Heart Failure Study (ADMIRE-HF), it has become clear that a simple ratio of heart-to-mediastinum (H/M) activity of I-123 metaiodobenzylguanidine (MIBG), on an anterior planar image is a strong predictor of cardiac prognosis in heart failure patients with a reduced left ventricular ejection fraction and New York Heart Association class II or III symptoms. The planar I-123 MIBG H/M ratio provides predictive information for outcome in heart failure patients beyond that available from clinical variables, left ventricular ejection fraction, and b-type natriuretic peptide.
measurements without septal penetration using a mediumenergy all-purpose collimator. 2, 3 This suggests that the combination of iterative reconstruction and DSP might substantially improve quantitation of I-123 MIBG activity in the heart in patient studies. These previous investigations notwithstanding, the I-123 MIBG H/M ratio from SPECT imaging has not entered into common use due to a lack of a standardized and practical method for calculation of the H/M ratio, as well as the technical challenges of calculating the H/M ratio in heart failure patients with very low uptake of the tracer into the myocardium.
In their study, Chen et al. 4 describe a new method for calculating the I-123 MIBG H/M ratio from SPECT images. The method was initially developed by comparing its ability to separate abnormal I-123 MIBG H/M ratios in 53 patients with coronary artery disease, prior myocardial infarction, and left ventricular ejection fraction B40%, from 14 normal volunteers with no history of heart disease. Three versions of the SPECT method (filtered back-projection, iterative reconstruction, and iterative reconstruction with DSP) plus a standard planar H/M method were then tested for their ability to separate 957 heart failure patients from 94 controls from the ADMIRE-HF study. Using receiver operator characteristics (ROC) analysis, the SPECT method with iterative reconstruction and the planar H/M ratio method provided comparable separation of heart failure patients from controls. A finding that was likely unexpected is that iterative reconstruction with DSP did not separate patients from controls as effectively as iterative reconstruction alone.
Improved separation of I-123 MIBG activity in the heart from background and scattered activity results in larger values of the H/M ratio with the SPECT compared to planar methods. Merlet et al. 5 provided an early report documenting the high risk for adverse cardiac events in patients with a planar H/M ratio less than 1.2. In the ADMIRE-HF study, 1 a planar value of 1.6 was prospectively tested to separate high-risk from low-risk patients. The value of 1.6 represents two standard deviations below the mean planar H/M ratio in normal subjects as reported in the literature. In the present study, the optimal cut-off value for the planar H/M ratio for separating heart failure patients from controls in the validation cohort was 1.58, and the optimal H/M ratio using SPECT imaging with iterative reconstruction was 2.61. This difference likely represents less contamination of the heart region of interest from background activity with SPECT compared to planar imaging. It suggests that SPECT imaging has the potential to permit more accurate quantitation of the H/M ratio than planar methods.
The method for quantitation of H/M ratio from SPECT I-123 MIBG images reported by Chen et al. 4 is a much needed step forward in the development of cardiac neuronal imaging. The same severe reduction in cardiac I-123 MIBG activity that is highly predictive of adverse cardiac events in heart failure patients also results in great challenges in measurement of radiotracer activity in the myocardium on SPECT images. Anyone who has interpreted I-123 MIBG images, and SPECT MIBG images in particular, knows that accurate delineation of the myocardial borders in a heart failure patient with severely reduced radiotracer activity in the myocardium can be very challenging. The high intra-observer and interobserver agreements for SPECT I-123 MIBG H/M ratio calculation using this new SPECT method is very encouraging. A theoretic advantage of SPECT over planar quantitation of myocardial I-123 MIBG activity is better separation of myocardial from background activity with tomography. This, however, raises the question of whether the myocardium could be more effectively separated from the left ventricular blood pool by an edge-tracking method that accurately traces the myocardial outline excluding the blood pool. With their method, the authors have chosen not to try to exclude the left ventricular cavity from the heart region of interest. This would appear to be a necessary concession given the low I-123 MIBG cardiac count density in patients with severe heart failure.
Potentially valuable information from SPECT imaging of I-123 MIBG activity in the heart is not limited to the H/M ratio. Well-validated, reproducible, widely applicable approaches to other measurements from SPECT I-123 MIBG imaging are needed. For example, planar SPECT imaging of I-123 MIBG washout from the myocardium over 3-4 hours has been shown to be predictive of sudden cardiac death, 6, 7 but SPECT approaches to quantitation of I-123 MIBG washout have received limited attention. In patients with an implantable cardioverter-defibrillator (ICD), Boogers et al. 8 reported that during 3 years of follow-up, 52% of patients with a large late I-123 MIBG SPECT defect received appropriate ICD therapy compared with 5% of patients with a small late I-123 MIBG SPECT defect (P \ 0.01). This underscores the potential need for accurate, reproducible, and generally available software to quantitate I-123 MIBG SPECT defect size. SPECT also offers an important method to quantitate regional myocardial distribution of I-123 MIBG activity. Regional inhomogeneity of I-123 MIBG activity has been reported in patients with increased risk of sudden cardiac death, including arrhythmogenic right ventricular cardiomyopathy, 9 Brugada syndrome, 10, 11 and Long QT syndrome. 12, 13 Clarification of possible regional differences in sympathetic innervation could be facilitated by accurate quantitation of regional I-123 MIBG distribution using SPECT imaging. It has also been observed that a distribution mismatch of myocardial perfusion and innervation may provide a substrate for life-threatening ventricular arrhythmias. [14] [15] [16] Therefore, SPECT assessment of H/M ratio is only one of several potentially important applications of SPECT imaging of cardiac innervation.
It is not clear why the addition of DSP to iterative reconstruction did not contribute positively to the accuracy of SPECT for separating heart failure patients from controls in the present study. Before dismissing the DSP approach completely, it is important to appreciate a fundamental limitation of the present study. It is highly unlikely that I-123 MIBG will find a practical clinical role for separating patients with heart failure (or patients with ischemic heart disease) from control subjects. The promising clinical role for I-123 MIBG relates to its prognostic (rather than diagnostic) capabilities. The clinical outcomes of the heart failure patients in the ADMIRE-HF study are already known. The critically important next steps are to assess whether the iterative reconstruction SPECT method for H/M ratio calculation as reported by Chen et al is predictive of adverse cardiac events, whether it predicts events as well or better than the planar method, and to see whether addition of DSP provides any benefit in determining prognosis.
